LLY compared with OCUL: revenue, margins and what each company keeps, and the suppliers and customers both name

LLYELI Lilly & Co

Mkt capRevenueRevenue

OCULOcular Therapeutix, Inc

Mkt capRevenueRevenue

Compare

LLYELI Lilly & Co

OCULOcular Therapeutix, Inc

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

LLY

3 of 4at or beyond implied

Reportimpliedrealized× implied

Q3 FY26±5.1%▲+6.63%×1.29

Q2 FY26±6.2%▲+4.86%×0.79

Q1 FY26±5.3%▲+9.80%×1.85

Feb 4 '26±6.1%▲+10.33%×1.69

OCUL

0 of 4at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±13.6%▲+2.82%×0.21

Q1 FY26±8.0%▼−0.61%×0.07

= impliedLLY realized, solidOCUL realized, hatchedOne scale, both sides: full bar = 51%× = |realized| ÷ impliedSource: market data

Feb 5 '26

±50.7%

▲+4.21%

×0.08

Nov 4 '25±10.3%▼−4.47%×0.44

LLYELI Lilly & Co

1,366.79▲+0.15%

Mkt cap$1.2TRevenue$24.4BQ3 FY26Revenue$65.2BFY25

OCULOcular Therapeutix, Inc

6.68▲+3.93%

Regular sessionNov 6 '26

Mkt cap$1.4BRevenue$13MQ2 FY26Revenue$52MFY25

Compare

Regular sessionNov 6 '26

LLYELI Lilly & Co

OCULOcular Therapeutix, Inc

1,366.79▲+0.15%

Price

6.68▲+3.93%

$1.2T

Mkt cap

$1.4B

Q3 FY26$24.4B

Revenue

$13MQ2 FY26

FY25$65.2B

Revenue

$52MFY25

LLY1,366.79▲+0.15%vsOCUL6.68▲+3.93%Regular sessionNov 6 '26